{
  "main_header": {
    "sid": 1117927,
    "name": "Pulike Biological Engineering, Inc.",
    "stock_name": "Pulike Biological Engineering, Inc.",
    "full_name": "Pulike Biological Engineering, Inc.",
    "name_url": "stocks-analysis/pulike-biological-engineering-inc",
    "exchange": 47,
    "exchangecode": "SHG",
    "country_id": 12,
    "currency": "CNY",
    "cmp": "13.02",
    "chg": -0.09,
    "chgp": "-0.69%",
    "dir": -1,
    "prev_price": "13.11",
    "mcapval": "4,776.82",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "China Shanghai Composite",
    "isin": "CNE1000025N0",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "5.91 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pulike-biological-engineering-inc-1117927-47&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Pulike Biological Engineering, Inc. Reports Strong Financial Performance in Q1 2025",
        "link": "https://www.marketsmojo.com/news/mojo-premium/pulike-biological-engineering-inc-joins-reliable-performers-strategy-amid-strong-financial-results-3565573",
        "imagepath": "",
        "date": "2025-09-24 14:54:04",
        "description": "<p><strong>Pulike Biological Engineering, Inc.</strong>, a small-cap player in the Pharmaceuticals & Biotechnology sector, has reported a robust financial performance for the quarter ending March 2025. The company has achieved significant milestones in its financial metrics, indicating a positive trajectory for its operations.</p>\n\n<p>One of the standout figures from the latest financial results is the operating cash flow, which reached its highest level at CNY 319.58 MM. This impressive cash flow performance underscores the company's ability to generate liquidity from its core operations, a crucial factor for sustaining growth and investment in future projects.</p>\n\n<p>Additionally, <strong>Pulike Biological Engineering, Inc.</strong> has successfully managed its raw material costs, which have decreased by 2.82% year-over-year. This reduction in costs not only enhances the company's profitability but also ..."
      }
    ],
    "total": 1,
    "sid": "1117927",
    "stock_news_url": "https://www.marketsmojo.com/news/pulike-biological-engineering-inc-1117927"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Pulike Biological Engineering, Inc. Reports Strong Financial Performance in Q1 2025

2025-09-24 14:54:04

Pulike Biological Engineering, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reported a robust financial performance for the quarter ending March 2025. The company has achieved significant milestones in its financial metrics, indicating a positive trajectory for its operations.

One of the standout figures from the latest financial results is the operating cash flow, which reached its highest level at CNY 319.58 MM. This impressive cash flow performance underscores the company's ability to generate liquidity from its core operations, a crucial factor for sustaining growth and investment in future projects.

Additionally, Pulike Biological Engineering, Inc. has successfully managed its raw material costs, which have decreased by 2.82% year-over-year. This reduction in costs not only enhances the company's profitability but also ...

Read More

View All News